Filing Details
- Accession Number:
- 0001567619-21-016336
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-25 17:47:06
- Reporting Period:
- 2021-08-23
- Accepted Time:
- 2021-08-25 17:47:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835824 | Harald Reinhart | C/O Zai Lab Limited 4560 Jinke Road, Bldg 1, 4Th Floor Pudong, Shanghai F4 201210 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-08-23 | 8,000 | $17.99 | 8,000 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-08-23 | 8,000 | $135.00 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2021-08-24 | 8,000 | $17.99 | 8,000 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-08-24 | 8,000 | $143.36 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2021-08-23 | 8,000 | $0.00 | 8,000 | $17.99 |
| Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2021-08-24 | 8,000 | $0.00 | 8,000 | $17.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,000 | 2028-11-16 | No | 4 | M | Direct | |
| 30,000 | 2028-11-16 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.
Billionaire Hedge Funds
